Funder: American Cancer Society
Due Dates: June 1, 2026 | December 1, 2026
Funding Amounts: Up to $75,000 total costs for a 1-year project; indirect costs are not allowed.
Summary: Supports key commercialization experiments for ongoing cancer research, helping to validate and de-risk technologies for market translation.
Key Information: For ongoing projects with a clear commercialization plan; applicants must be independent investigators at eligible US nonprofit institutions.